How the Hawaii wildfires spread so quickly
By Gloria Dickie, Clare Trainor, Daisy Chung and Travis Hartman LONDON The wildfire that ripped through Lahaina on
2023-08-21 21:18
Maui children face grief, destruction as schools start up after wildfire
By Sharon Bernstein Before wildfire ravaged the Hawaiian community of Lahaina last week, high school teacher Mike Landes
2023-08-19 18:25
Hawaii wildfires: Why identifying the victims could take years
"It's not just ash on your clothing when you take it off," says a police chief. "It's our loved ones."
2023-08-16 08:56
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
2023-08-07 20:15
Can You Solve the World’s First Crossword Puzzle?
Try your hand at the 1913 diamond grid that kicked off the crossword puzzle craze.
2023-08-04 03:20
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Expansion
Biogen Inc. agreed to acquire Reata Pharmaceuticals Inc. for $7.3 billion including debt to expand its rare disease
2023-07-28 19:49
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:45
Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end
2023-07-11 09:46
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
Michael Rubin's July 4 'White Party' Featured Absurd Cast of Famous People
A truly wild affair.
2023-07-05 21:45
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:22